Skip to main content
颖泰生物 logo

颖泰生物 — Investor Relations & Filings

Ticker · 920819 Beijing Stock Exchange Manufacturing
Filings indexed 419 across all filing types
Latest filing 2022-04-14 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920819

About 颖泰生物

https://www.nutrichem.cn/

Nutrichem Company Limited focuses on the research, development, production, and distribution of agrochemical active ingredients and formulations. The product portfolio includes a diverse array of herbicides, fungicides, and insecticides tailored for global agricultural applications. The company provides comprehensive contract development and manufacturing organization (CDMO) services, supporting international partners through the entire product lifecycle from synthesis to commercial-scale production. With a strong emphasis on research and development, Nutrichem utilizes advanced chemical synthesis technologies and process optimization to ensure high-quality output and operational efficiency. Its integrated supply chain and large-scale manufacturing infrastructure enable the delivery of customized crop protection solutions to meet the evolving needs of the global agricultural sector.

Recent filings

Filing Released Lang Actions
关于收到北京证券交易所对公司2021年年度报告问询函的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Beijing Yingtai Jiahe Biotechnology Co., Ltd. regarding the receipt of an inquiry letter from the Beijing Stock Exchange about the company's 2021 Annual Report. The text includes detailed questions and requests for explanations related to various financial and accounting matters in the 2021 Annual Report, such as asset impairment, goodwill impairment, accounts receivable, inventory, revenue, investment income, and accounting policies. However, the document itself does not contain the full annual report or the actual financial statements; rather, it is a regulatory inquiry and request for supplementary information related to the annual report. The document length is 4617 characters, which is relatively short and consistent with an announcement or inquiry rather than a full report. According to the classification rules, documents that announce or discuss reports but do not contain the full report or substantive financial data should be classified as Regulatory Filings (RNS). Therefore, this document is best classified as a Regulatory Filing (RNS).
2022-04-14 Chinese
2021年年度股东大会决议公告
AGM Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2021 Annual General Meeting (AGM) of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It includes information about the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting. The document references the 2021 Annual Report and other reports but does not contain the reports themselves. The content is focused on the AGM proceedings and voting outcomes rather than the full annual report or financial statements. The document length is 4492 characters, which is relatively short and consistent with an AGM resolution announcement rather than a full report. Therefore, the appropriate classification is AGM Information (AGM-R).
2022-04-12 Chinese
北京市康达律师事务所关于北京颖泰嘉和生物科技股份有限公司2021年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, and voting procedures of the 2021 Annual General Meeting (AGM) of Beijing Yingtai Jiahe Biotechnology Co., Ltd. It details the legality and validity of the AGM process, including the notice, attendance, voting results, and compliance with relevant laws and company regulations. The document does not contain the actual annual report or financial statements but rather provides a legal opinion on the AGM proceedings and voting outcomes. This type of document is typically associated with the Declaration of Voting Results & Voting Rights Announcements category, as it reports official voting results from the AGM.
2022-04-12 Chinese
投资者关系活动记录表
Investor Presentation Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record". It specifically mentions an "业绩说明会" which means "Performance Explanation Meeting" or "Earnings Presentation". The content includes a Q&A session with company executives discussing the company's 2021 annual performance, R&D, financing, and other operational details. The document is relatively short (2132 characters) and focuses on the discussion and explanation of the annual report results rather than presenting the full financial statements or detailed data. This matches the characteristics of an Investor Presentation (IP) rather than a full Annual Report (10-K) or Earnings Release (ER). It is not a report publication announcement or a regulatory filing. Therefore, the best classification is Investor Presentation (IP).
2022-03-31 Chinese
2021年度报告说明会预告公告
AGM Information Classification · 95% confidence The document is a notice announcing a scheduled meeting to discuss the company's 2021 Annual Report. It references the already published 2021 Annual Report (announcement number 2022-015) and provides details about the date, time, and format of the performance explanation meeting. The document itself does not contain the annual report or detailed financial data but serves as an announcement for the upcoming annual report presentation event. According to the 'Menu vs Meal' rule, such a notice is classified as AGM Information (AGM-R) because it relates to the Annual General Meeting or similar shareholder meeting presentations and materials.
2022-03-21 Chinese
四川华信(集团)会计师事务所(特殊普通合伙)关于北京颖泰嘉和生物科技股份有限公司2021年度非经营性资金占用及其他关联资金往来情况专项审核说明
Regulatory Filings
2022-03-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.